C12N 2710/10052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2710/10052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 15 US grants and 39 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 39
- Assignees
- 31
- Inventors
- 98
- Latest grant
- 29 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 5 |
| 2016 | 1 | 4 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 0 | 4 |
| 2025 | 2 | 5 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fast and accurate three-plasmid oncolytic adenovirus recombinant packaging system Ad5MixPlus and application thereof29 Jul 2025US 12,371,670 B2Voncolytic Therapeutics Co., Ltd.
- Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof21 Jan 2025US 12,203,094 B2Homology Medicines, Inc.
- Method, system and recombinant bacmid for preparation of recombinant adeno-associated virus25 Jul 2023US 11,708,585 B2Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences
- Cell line for producing adenovirus and method of preparing the same12 Apr 2022US 11,299,713 B2Geneuin-Tech Co., Ltd.
- Adeno-associated-virus Rep sequences, vectors and viruses16 Mar 2021US 10,947,514 B2The Research Foundation for The State University of New York
- Adenoviral vector vaccine, and preparation method and use thereof10 Sep 2026US 2026/0265702 A1Cansino Biologics Inc.
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Method for releasing viral vectors16 Apr 2026US 2026/0103730 A1PCI Biotech AS
- Method for the manufacture of recombinant adenovirus vectors20 Nov 2025US 2025/0354170 A1Ferring International Center S.A.
- Exogenous gene controllable expression virus packaging vector and packaging method4 Sep 2025US 2025/0277233 A1
Most cited
By later US patents
- Selective cell targeting using adenovirus and chemical dimers24US 9,913,866 B2The Salk Institute for Biological Studies · 2018
- Non-adenoviral gene product-based complementing cells for adenoviral vectors22US 6,677,156 B2GenVec, Inc. · 2004
- Recombinant serotype 5 (Ad5) adenoviral vectors16US 9,410,129 B2Targovax Oy · 2016
- Means and methods to increase adenovirus production10US 10,240,128 B2Sirion Biotech GmbH · 2019
- Replicating recombinant adenovirus vectors, compositions, and methods of use thereof9US 9,750,801 B2Beth Israel Deaconess Medical Center, Inc. · 2017